A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

• Status: Not yet recruiting
• Trial end date: 2025-08-08

Summary

The purpose of this study is to evaluate efficacy and safety of an oral bedaquiline-containing multidrug-resistant tuberculosis (MDR-TB) short-course regimen (SCR) compared to an oral SCR not including bedaquiline at the end of treatment in participants with pulmonary MDR-TB in China.

• Phase: Phase 4

Details

• Lead Sponsor: Beijing Chest Hospital
• Treatments: Bedaquiline; Clofazimine; Cycloserine; Levofloxacin; Linezolid; Ofloxacin; Prothionamide; Pyrazinamide